These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11759366)

  • 1. New advances in the treatment of sickle cell disease: focus on perioperative significance.
    Dix HM
    AANA J; 2001 Aug; 69(4):281-6. PubMed ID: 11759366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N
    Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea in the treatment of sickle-cell anemia.
    Howard LW; Kennedy LD
    Ann Pharmacother; 1997 Nov; 31(11):1393-6. PubMed ID: 9391697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
    Yale SH; Nagib N; Guthrie T
    Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of hydroxyurea on hemoglobin S].
    Torres AF; Eberle SE; Sciuccati G; Bonduel M
    Medicina (B Aires); 2003; 63(2):140-2. PubMed ID: 12793083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea for children with sickle cell disease.
    Heeney MM; Ware RE
    Pediatr Clin North Am; 2008 Apr; 55(2):483-501, x. PubMed ID: 18381097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified poloxamer 188 for sickle cell vaso-occlusive crisis.
    Gibbs WJ; Hagemann TM
    Ann Pharmacother; 2004 Feb; 38(2):320-4. PubMed ID: 14742772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
    Al-Jam'a AH; Al-Dabbous IA
    Saudi Med J; 2002 Mar; 23(3):277-81. PubMed ID: 11938415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How I treat ... sickle cell anemia: current therapies].
    Rezaei Kalantari H
    Rev Med Liege; 2001 Oct; 56(10):671-5. PubMed ID: 11765575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hydroxyurea and other agents stimulating synthesis of fetal hemoglobin].
    de Montalembert M
    Pathol Biol (Paris); 1999 Jan; 47(1):55-8. PubMed ID: 10081780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute pancreatitis during sickle cell vaso-occlusive painful crisis.
    Ahmed S; Siddiqui AK; Siddiqui RK; Kimpo M; Russo L; Mattana J
    Am J Hematol; 2003 Jul; 73(3):190-3. PubMed ID: 12827657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
    Okam MM; Ebert BL
    Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal and hepatic complications of sickle cell disease.
    Ebert EC; Nagar M; Hagspiel KD
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):483-9; quiz e70. PubMed ID: 20215064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
    Wood KC; Granger DN
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Established and experimental treatments for sickle cell disease.
    De Franceschi L; Corrocher R
    Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle cell patients find a brand New World.
    Noonan SS
    N J Med; 1999 Aug; 96(8):23-5. PubMed ID: 10457727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.